Decintas 50 mg Injection
48,16$
41,32$
Decintas 50 mg Injection is a targeted therapy designed to combat myelodysplastic syndrome, a condition characterized by the ineffective production of healthy blood cells in the bone marrow, leading to an excess of immature cells known as blasts. This innovative treatment works by helping to restore the normal function of the bone marrow, promoting the formation of healthy blood cells and improving overall blood counts. Patients receiving Decintas should be aware of potential side effects, including risk of infection and bleeding, which necessitate regular monitoring by healthcare professionals. It is crucial to inform your doctor of any existing health conditions or medications being taken to avoid adverse interactions. Decintas is administered via injection, making it a convenient option for those in need of ongoing treatment. This medication represents a significant advancement in the management of myelodysplastic syndrome, providing hope for patients seeking effective therapeutic solutions. Always consult with your healthcare provider for personalized medical advice and treatment plans tailored to your individual needs. With Decintas, patients can take an important step toward regaining control over their health and enhancing their quality of life.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Decintas 50 mg injection is primarily indicated for the treatment of myelodysplastic syndrome (MDS). MDS is characterized by the production of abnormal blood cells in the bone marrow, which can lead to insufficient healthy blood cell counts. Patients may experience symptoms such as fatigue, weakness, and shortness of breath due to these deficiencies. The administration of Decintas 50 mg injection aims to improve blood cell production and enhance overall patient health.
• This medication is also utilized in the management of acute myeloid leukemia (AML). AML is a type of blood cancer that disrupts the normal production of myeloid cells, leading to an overproduction of immature cells. Symptoms of AML can be severe, including frequent infections and easy bruising. Decintas 50 mg injection plays a crucial role in targeting these abnormal cells, helping to restore balance within the blood cell population.
• In patients suffering from both MDS and AML, Decintas 50 mg injection can provide a vital therapeutic option. The medication helps to mitigate the debilitating effects of these conditions by promoting healthier blood cell formation. By addressing the underlying issues associated with these disorders, Decintas 50 mg injection contributes to improved patient outcomes. Regular monitoring and administration of this injection are essential for managing symptoms effectively.
• Decintas 50 mg injection is often part of a comprehensive treatment plan for individuals diagnosed with MDS or AML. It may be administered alongside other therapies to enhance its effectiveness and support overall patient care. The goal of using Decintas 50 mg injection is to improve quality of life by alleviating symptoms and increasing blood cell counts. Healthcare providers may tailor treatment regimens based on the specific needs of each patient to achieve optimal results.
Benefits
Myelodysplastic syndrome: Decintas 50 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function and does not produce enough healthy blood cells. Decintas Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid leukemia (AML): Anti-cancer Drug Decintas is used to treat acute myeloid leukemia, a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Decitabine Injection 50 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Insomnia
• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Stomach pain
• Painful sores in mouth or tongue or lips
• Indigestion
• Heartburn
• Rashes
• Itching
• Hair loss
• Skin discolouration
• Chest discomfort
• Muscle pain
• Joint pain
• Swelling over extremities
• Pain or swelling or redness over the injection site
• Weakness
• Confusion
• Headache
• Dizziness
• Extreme weakness
Common Side Effects
• Bruising
• Unusual bleeding
• Facial swelling
• Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
• Sore throat
• High
• grade fever with chills
• Other signs of infection
How To Use
Decintas 50 mg Injection is available in powder form, which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Decitabine Injection 50 mg is administered by a doctor or nurse at a hospital or clinical setting. The dosage, frequency, and interval (duration of infusion) depend upon your medical condition, body size, lab test results, and response towards the treatment given. Don't administer this drug by yourself; it must be administered under medical supervision by healthcare professionals only. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Decintas 50 mg.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Decintas 50 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Decintas 50 mg Injection is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Decintas 50 mg Injection is recommended. The use of Decintas 50 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Decintas 50 mg. Decintas 50 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Decintas 50 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Decintas 50 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.
• Pregnancy: Use of Decintas 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Decintas 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Decintas 50 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Decintas 50 mg.